A new discovery shows promise against the neurological effects of Lyme disease. Scientists may have found a way to effectively counter the neurological symptoms of Lyme disease.
Researchers seek to develop vaccine against plague, tularemia and melioidosis outbreaknewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outbreaknewstoday.com Daily Mail and Mail on Sunday newspapers.
SAN FRANCISCO (KGO) While COVID-19 is by far the most widespread threat, it s also just the latest in a progression of dangerous viruses, including the deadly outbreak of SARS in the early 2000s, and another known as MERS that emerged first in the Middle East.
Now, Stanford Researcher Peter Kim, Ph.D., and his team are on the trail of a vaccine that s cheap and easily transportable. Our goal was to create a vaccine that was protein only, that would be a single shot vaccine and would be room temperature stable. And our hope is that such a vaccine could be used in lower-middle income countries, explains Kim.
Bay Area researchers developing COVID vaccine to protect against future variants
KTVU s Tom Vacar reports.
LIVERMORE, Calif. - A Bay Area laboratory is helping come up with the technology that could make worldwide pandemics far easier and quicker to defeat.
The Lawrence Livermore National Laboratory, which assures the safety, security, and reliability of America s nuclear weapons, is working to develop a vaccine to protect against future mutations.
Lawrence Livermore National Laboratory (LLNL) partnered up with UK biotech company ConserV Bioscience to create a universal coronavirus vaccine.
ConserV Bioscience’s expertise is in identifying substances that can induce an immune response in the body, substances called antigens.
Lawrence Livermore National Laboratory announced this week a new collaboration with a United Kingdom company to develop a broad-spectrum or "universal" coronavirus vaccine.